Results From The WOW.Com Content Network
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevriaand Covishield,is a viral vector vaccineproduced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations.
Prevnar™ (PCV7)–the original PCV vaccine–was a heptavalent vaccine, meaning that it contains the cell capsule sugars of seven serotypes of the bacteria S. pneumoniae (4, 6B, 9V, 14, 18C, 19F, and 23F) conjugated with diphtheria proteins. It was manufactured by Wyeth (which was acquired by Pfizer ). 
Polio vaccine - Wikipedia Polio vaccine Polio vaccines are vaccines used to prevent poliomyelitis (polio).  Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV).  The World Health Organization (WHO) recommends all children be fully vaccinated against polio. 
By April 19, 2021, all U.S. states had opened vaccine eligibility to residents aged 16 and over.  On May 10, 2021, the FDA approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15.  On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals aged 16 and over. 
It is an mRNA vaccine composed of nucleoside-modified mRNA (modRNA) encoding a spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles.  It is authorized for use at some level in many countries.    
Common side effects of COVID-19 vaccines include soreness, redness, rash, inflammation at the injection site, fatigue, headache, myalgia (muscle pain), and arthralgia (joint pain), which resolve without medical treatment within a few days.
Pentavalent vaccine frequently refers to the 5-in-1 vaccine protecting against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenzae type B,  which is generally used in middle- and low-income countries, where polio vaccine is given separately.  
e. The Oxford–AstraZeneca COVID‑19 vaccine , sold under the brand names Covishield  and Vaxzevria   among others, is a viral vector vaccine for prevention of COVID-19. Developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca,    using as a vector the modified chimpanzee adenovirus ...